Tiger Eye Capital LLC Nevro Corp Transaction History

Tiger Eye Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$59.95 - $92.06 $188,063 - $288,792	-3,137 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$132.81 - $182.18 $31.3 Million - $43 Million	-235,985 Reduced 98.69%	3,137 $438,000
Q4 2020 Feb 16, 2021	BUY	$138.17 - $184.34 $13 Million - $17.3 Million	93,969 Added 64.74%	239,122 $41.4 Million
Q3 2020 Nov 13, 2020	SELL	$114.09 - $145.51 $5.43 Million - $6.93 Million	-47,601 Reduced 24.7%	145,153 $20.2 Million
Q2 2020 Aug 13, 2020	BUY	$89.45 - $129.85 $17.2 Million - $25 Million	192,754 New	192,754 $23 Million
Q1 2020 May 15, 2020	SELL	$70.23 - $144.31 $16.7 Million - $34.3 Million	-237,883 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$76.41 - $117.54 $1.01 Million - $1.56 Million	-13,244 Reduced 5.27%	237,883 $28 Million
Q3 2019 Nov 14, 2019	BUY	$61.52 - $91.1 $5.52 Million - $8.18 Million	89,806 Added 55.67%	251,127 $21.6 Million
Q2 2019 Aug 14, 2019	BUY	$58.04 - $66.99 $9.36 Million - $10.8 Million	161,321 New	161,321 $10.5 Million

168

37.8M

44K

1.69M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $193M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Tiger Eye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Tiger Eye Capital LLC with notifications on news.